Heron Therapeutics（纳斯达克代码：HRTX）报告季度每股收益为$0.02，超出分析师一致预期的$(0.03)，上涨166.67%。相比去年同期的每股亏损$(0.07)，这一收益增长了128.57%。公司报告的季度销售额为$40.78M，超出分析师预期的$37.37M，增长了9.14%。相比去年同期的$34.23M，销售额增长了19.13%。

以上内容来自Benzinga Earnings专栏，原文如下：

Heron Therapeutics (NASDAQ:HRTX) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.03) by 166.67 percent. This is a 128.57 percent increase over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $40.78 million which beat the analyst consensus estimate of $37.37 million by 9.14 percent. This is a 19.13 percent increase over sales of $34.23 million the same period last year.